Fig. 1From: Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplantsPharmacokinetic profiles. Graphs show pharmacokinetic profiles of Sandimmun®Optoral (a) and Ciclosporin Pro (b) taken after 10 h of fasting or high-fat breakfast. Parts (c) and (d) illustrate the difference between Sandimmun®Optoral and Ciclosporin Pro in these conditionsBack to article page